SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7630Looks as though any information on FDA acceptance of resubmission may be baked iquidditch-7/8/2004
7629IVAX Receives FDA Approvable Letter for Albuterol HFA in Breath-Activated InhaleIcebrg-7/7/2004
7628<i> local school supplies store, as "Coulter" pencils.</i>Biomaven-7/6/2004
7627Those are no longer called "number two" pencils. They are now referrescaram(o)uche-7/6/2004
7626<i>What are they going to say, you skipped question 19? :-)</i> MorBiomaven-7/6/2004
7625I think the long weekend may have delayed things. I don't think there'rkrw-7/6/2004
7624<i>FDA division that is reviewing the re-submission changed to anesthesiolBiomaven-7/6/2004
7623Peter, that was my take as well, but you (collectively) know better than to takequidditch-7/6/2004
7622Thanks for the update Peter, This is all quite interesting. J.D.jayhawk969-7/6/2004
7621According to the company (as of a few minutes ago) they still haven't heard Biomaven-7/6/2004
7620Politics influences flow of Medicaid dollars Sunday, July 04, 2004 By SEAN REILLIcebrg-7/4/2004
7619<i> "Friday after the bell- long weekend" disclosure</i> Biomaven-7/2/2004
7618This market is looking for a stock it can love. Not a lot of good choices. An ajayhawk969-7/2/2004
7617I guess they're all in Nantucket or on the Vineyard. Early hours, yet, evenquidditch-7/1/2004
7616Well, here we are, at 14 days. Naked and exposed.jayhawk969-7/1/2004
7615Sanofi-Synthelabo: losing sleep over Ambien competition Sanofi has filed for USIcebrg-6/26/2004
7614<i>There is certainly enough vagueness in the 8-K language to permit a muljayhawk969-6/22/2004
7613bk: <I think it is proper for SEPR to be conservative about revealing label cquidditch-6/22/2004
7612I don't think there would have been much movement on label content at this tbio_kruncher-6/22/2004
7611<<I'm guessing that what Estorra is getting is a label with no such requidditch-6/21/2004
7610<i>what is the scope of wiggle room that the FDA has from the proposed labBiomaven-6/21/2004
7609Quid, Nice insight, I hope your wrong. It could explain the rush of presentatiojayhawk969-6/21/2004
7608LT label: Peter, other than (i) the management information on the Estorra approquidditch-6/21/2004
7607<i> ambien generics and costly copays </i> It's much harder forBiomaven-6/21/2004
7606I hope you're right. Amount of $ sepr is spending, the launch better go veryrkrw-6/21/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News